chop-daclizumab
Showing 1 - 1 of 1
HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL) Trial in London (CHOP-daclizumab)
Completed
- HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)
- CHOP-daclizumab
-
London, United KingdomKing's College Hospital NHS Foundation Trust
Aug 19, 2011